Ondansetron/Cyclodextrin inclusion complex nanofibrous webs for potential orally fast-disintegrating antiemetic drug delivery

buir.contributor.authorDurgun, Engin
buir.contributor.orcidDurgun, Engin|0000-0002-0639-5862
dc.citation.epage121921-12en_US
dc.citation.spage121921-1en_US
dc.citation.volumeNumber623en_US
dc.contributor.authorHsiung, E.
dc.contributor.authorCelebioglu, A.
dc.contributor.authorEmin Kilic, M.
dc.contributor.authorDurgun, Engin
dc.date.accessioned2023-02-24T13:04:41Z
dc.date.available2023-02-24T13:04:41Z
dc.date.issued2022-07-25
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.description.abstractOndansetron (ODS) is an effective antiemetic drug which suffers from limited solubility and bioavailability during oral administration due to first-pass metabolism. However, these limitations can be mitigated through inclusion complexation with cyclodextrins (CDs). In this study, we have reported the electrospinning of polymer-free, free-standing ODS/CD nanofibrous webs (NW), a promising approach for developing a fast-disintegrating delivery system of an antiemetic drug molecule. Highly water soluble hydroxypropyl-beta-cyclodextrins (HPβCD) were used as both complexation agent and electrospinning matrix. The computational study revealed that the 1/2 (drug/CD) stoichiometry was more favorable compared to 1/1. The ODS/HPβCD NW was obtained with higher loading efficiency (∼96 %) compared to the control sample of ODS/polyvinyl alcohol (PVA) NW (∼80 %). The amorphous distribution of ODS raised by complexation and the highly water-soluble nature of HPβCD resulted into faster and better release profile and quite faster disintegration property (∼2 s) in artificial saliva than polymeric ODS/PVA NW. Here, ODS/HPβCD NW was generated in the absence of a toxic solvent or chemical to enable the drug loading in an amorphous state. From all reasons above, ODS/HPβCD NW might be a promising alternative to the polymeric based systems for the purpose of fast-disintegrating oral drug delivery.en_US
dc.description.provenanceSubmitted by Bilge Kat (bilgekat@bilkent.edu.tr) on 2023-02-24T13:04:41Z No. of bitstreams: 1 Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf: 9711743 bytes, checksum: ae6a13d9dce24a3a46f47ccfbca05e8e (MD5)en
dc.description.provenanceMade available in DSpace on 2023-02-24T13:04:41Z (GMT). No. of bitstreams: 1 Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf: 9711743 bytes, checksum: ae6a13d9dce24a3a46f47ccfbca05e8e (MD5) Previous issue date: 2022-07-25en
dc.identifier.doi10.1016/j.ijpharm.2022.121921en_US
dc.identifier.eissn1873-3476
dc.identifier.issn0378-5173
dc.identifier.urihttp://hdl.handle.net/11693/111691
dc.language.isoEnglishen_US
dc.publisherElsevieren_US
dc.relation.isversionofhttps://doi.org/10.1016/j.ijpharm.2022.121921en_US
dc.source.titleInternational Journal of Pharmaceuticsen_US
dc.subjectElectrospinningen_US
dc.subjectCyclodextrinen_US
dc.subjectOndansetronen_US
dc.subjectFast disintegratingen_US
dc.subjectOral drug deliveryen_US
dc.subjectAntiemetic treatmenten_US
dc.titleOndansetron/Cyclodextrin inclusion complex nanofibrous webs for potential orally fast-disintegrating antiemetic drug deliveryen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ondansetron-Cyclodextrin_inclusion_complex_nanofibrous_webs_for_potential_orally_fast-disintegrating_antiemetic_drug_delivery.pdf
Size:
9.26 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description: